For the past nineteen years, Ioannis Tarnanas, the founder and chief scientific officer at Altoida, has been developing virtual and augmented reality tools to offer predictions about the onset of mental illness in older patients. The company, whose tools have been approved by the Food and Drug Administration for predicting Alzheimer’s, claims that it can…